喘患者遵守ICS/LAMA/LABA的分析:使用医疗索赔数据进行回顾性观察队列研究
Toru Oga1, Risako Ito2, Chifuku Mita3
1Department of Respiratory Medicine, Kawasaki Medical School, 577, Matsushima, Kurashiki, Okayama, 701-0192, Japan.
Respiratory investigation
|May 6, 2025
概括
在日本,患有喘的患者与多次吸入器三重治疗 (MITT) 相比,显著更好地坚持了单次吸入器三重治疗 (SITT) 的弗卢蒂卡松酸/尤克利迪尼/维兰特罗尔 (FF/UMEC/VI). 这项现实研究强调了SITT.的治疗坚持改善.
科学领域:
- 呼吸系统医学 呼吸系统医学
- 药物经济学 药物经济学
- 现实世界的证据.
背景情况:
- 对于日本的流动松酸/umeclidinium/vilanterol (FF/UMEC/VI),现实世界数据有限.
- 喘管理通常涉及复杂的吸入器疗法.
研究的目的:
- 为了比较日本喘的单吸入器三重疗法 (SITT) 和多吸入器三重疗法 (MITT) 之间的治疗坚持.
- 为了评估FF/UMEC/VI SITT与MITT的实际有效性.
主要方法:
- 使用日本索赔数据的回顾性观察队列研究 (2021年2月-2022年2月).
- 包括年龄≥15岁开始FF/UMEC/VI SITT或MITT的患者.
- 将治疗权重的逆概率应用于两个队列:整体和非初始维持疗法 (非IMT).
主要成果:
- 与MITT相比,FF/UMEC/VI SITT在启动后的3,6个月和12个月内观察到明显更高的坚持率.在整体和非IMT队列中.
- 3个月后,FF/UMEC/VI SITT的坚持率为36.4%,与MITT的31.2% (整体队列) 相比,36.6%与28.9% (非IMT队列).
- 权重利率比率表明,对SITT的遵守明显更好 (1.16在整体上,1.26在非IMT中).
结论:
- 在日本的喘患者中,单吸入器三重疗法 (SITT) 显示出比多吸入器三重疗法 (MITT) 更优异的治疗坚持.
- 改善SITT的坚持可能转化为更好的喘管理结果.
- 现实世界的证据支持FF/UMEC/VI SITT的使用,以提高日本患者的坚持.
相关概念视频
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
228
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
228
Antiasthma Drugs: Leukotriene Modifiers
253
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
253
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Antiasthma Drugs: β2-Adrenoceptor Agonists
239
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
239
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
251
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
251
Asthma-IV: Nursing Management
3.0K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.0K


